RTSL

RAPID THRPTIC SCIENCE LAB by Rapid Therapeutic Science Laboratories, Inc. (RTSL)

About RAPID THRPTIC SCIENCE LAB by Rapid Therapeutic Science Laboratories, Inc. (RTSL)

Rapid Therapeutic Science Laboratories, Inc. operates as an early stage emerging biotech company in the legal hemp and cannabis space. The company develops a new method of formulation and manufacturing to deliver pure CBD, THC, and combinations in legal jurisdictions to consumers. It holds a sublicense agreement to access certain technology regarding the Rxoid metered dose inhaler, which is a medical technology that delivers medication directly to a user's blood stream through the pulmonary tract. It serves customers in the state of Texas. The company was founded on February 22, 2013 and is headquartered in De Leon, TX.

Details

Daily high
$0.01
Daily low
$0.01
Price at open
$0.01
52 Week High
$0.01
52 Week Low
$0.00
Market cap
65,400
Dividend yield
0.00%
Volume
5,000
Avg. volume
1,560
P/E ratio
-.67

RAPID THRPTIC SCIENCE LAB by Rapid Therapeutic Science Laboratories, Inc. News

Details

Daily high
$0.01
Daily low
$0.01
Price at open
$0.01
52 Week High
$0.01
52 Week Low
$0.00
Market cap
65,400
Dividend yield
0.00%
Volume
5,000
Avg. volume
1,560
P/E ratio
-.67